Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Reduces board size to 8 members from 12, with non-executive directors Gabriel Urwitz, Peter Sjostrand, Allen Han and Yuelong Huang to depart. The four will step down at the company's annual general meeting, expected to be held in July. At that point, the board will comprise three executive directors and five non-executives.
Current stock price: 26.10 pence
12-month change: down 34%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
